COMP <GO>
NMAD vs RNTX // OPERATING MARGIN
Nomad Power Solutions Inc. (NASDAQ) VS. Rein Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: NMAD 1
— RNTX 1
■ METRIC PARITY
LAST: $3.52 (+1.44%) • MKT CAP: $55.9M
operating-margins
—
LAST: $0.67 (+5.05%) • MKT CAP: $54.8M
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NMAD VS. RNTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NMAD | RNTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.39% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.0 | 44.4 | -3.40 | RNTX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $55.9M | $54.8M | $1.1M | NMAD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NMAD REV | RNTX REV | NMAD GROSS % | RNTX GROSS % | NMAD FCF | RNTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $14.3M | $141.8M | — | — | -$3.1M | -$19.4M |
| FY 2024 | $10.0M | $182.3M | — | — | -$3.2M | -$22.3M |
| FY 2023 | $14.3M | $45.6M | — | — | -$4.3M | -$19.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NMAD // BETA —
RNTX // BETA —